Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 6, Issue 10, Pages 2308-2320
Publisher
Wiley
Online
2017-08-23
DOI
10.1002/cam4.1124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTOR and PDGF Pathway Blockade Inhibits Liver Metastasis of Colorectal Cancer by Modulating the Tumor Microenvironment
- (2015) Ryo Yuge et al. AMERICAN JOURNAL OF PATHOLOGY
- The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
- (2015) Jenny J Ko et al. LANCET ONCOLOGY
- Cancer-associated fibroblasts promote renal cell carcinoma progression
- (2015) Yunze Xu et al. TUMOR BIOLOGY
- Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody
- (2015) Juqun Shen et al. NEOPLASIA
- Combining Molecular Targeted Drugs to Inhibit Both Cancer Cells and Activated Stromal Cells in Gastric Cancer
- (2015) Mieko Onoyama et al. NEOPLASIA
- Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
- (2014) Terence O'Reilly et al. Translational Oncology
- Relationships between the Effect of Sunitinib and Immature Blood Vessels in Metastatic Renal Cell Cancer
- (2014) Byung Hoon Kim et al. UROLOGIA INTERNATIONALIS
- Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer
- (2013) R Rosa et al. BRITISH JOURNAL OF CANCER
- Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer
- (2012) Kei Shinagawa et al. INTERNATIONAL JOURNAL OF CANCER
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model
- (2010) Tomonori Sumida et al. INTERNATIONAL JOURNAL OF CANCER
- Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
- (2010) Christina Hägglöf et al. PLoS One
- Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
- (2009) Janna Paulsson et al. AMERICAN JOURNAL OF PATHOLOGY
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now